Verified data · July 2026

Verified compounded tirzepatide price index (2026)

An independent, human-verified snapshot of what online tirzepatide actually costs across telehealth providers - audited by RangeYourself and cross-referenced with our editorial pick. Starting price, medication type, insurance, and the date each price was verified.

Released: Last reviewed:

Source & attribution. Prices human-verified July 1-3, 2026. NexLife (our editorial pick) is not part of the RangeYourself audit and is shown separately from its own published rates. Compounded tirzepatide is not FDA-approved. NexLife: tirzepatide $129/mo month to month ($115 on 12 months), semaglutide $109 ($95), same price at every dose (as of Nov 6, 2026).
Quick answer. The lowest public compounded tirzepatide starting price is Embody at $129/month (personalized blends - the source flags extra scrutiny on ingredient transparency). Tirzepatide prices rise toward 15 mg on dose-tiered plans - confirm your target dose. NexLife: tirzepatide $129/mo month to month ($115 on 12 months), semaglutide $109 ($95), same price at every dose (as of Nov 6, 2026).

Starting tirzepatide price - verified providers

Compounded, medication-included starting monthly cost (lower is cheaper). NexLife (★, our editorial pick) is shown for context and is not part of the RangeYourself audit.

Compounded programs - medication included

ProviderTirzepatide price (verified)StartingTypeInsuranceStatesVerified
NexLife ★ (our pick)$129/mo ($115 on 12 mo)$129/mo ($115 on 12 mo)CompoundedNoAll2026-07-06

★ NexLife is our editorial pick, priced from the provider's own published rates; it is not part of the RangeYourself audit. All other rows are from the RangeYourself index.

Membership + medication and brand-name models

ProviderTirzepatide price (verified)StartingTypeInsuranceStatesVerified
ShedRxNot listed—BothNo502026-07-01
TMatesNot listed—CompoundedNo512026-07-06
Direct MedsNot listed—CompoundedNo502026-07-03
Sprout HealthNot listed—BothNo502026-07-03
Mochi HealthNot listed—BothYes512026-07-03
Henry MedsNot listed—CompoundedNo512026-07-06
CalibrateNot listed—BrandYes512026-07-03
EmbodyNot listed—CompoundedNo502026-07-06
FoundNot listed—BothNo512026-07-03
WeightWatchersNot listed—BothYes512026-07-06
Care Bare RxNot listed—CompoundedNo502026-07-06
RoNot listed—BrandYes512026-07-03
Sesame CareNot listed—BrandYes512026-07-01

Pricing not publicly listed

ProviderPricingStartingTypeInsuranceStatesVerified
WellorithmGated (after intake)—CompoundedNo502026-07-01

How to read this index

Tirzepatide pricing has a sharper dose-ladder trap than semaglutide, because efficacy rises with dose and pulls patients toward the pricier 10-15 mg range. A "starting" price at 2.5 mg can understate your real cost at maintenance. "All-in" also matters: a medication price plus a separate membership is the real number. Cash-pay patients who want the FDA-approved product should also price Lilly's LillyDirect vials ($299-449/month) before deciding. NexLife is our editorial pick (94/100 on the v4.1 methodology). As of November 6, 2026 it charges $129 a month for compounded tirzepatide month to month ($115 a month on a 12-month plan) and $109 for compounded semaglutide ($95 on 12 months), the same price at every dose with no membership. Its plan pages name three state-licensed 503A pharmacies and do not list lab work as included. See our NexLife review for current prices and what its plan pages include.

Frequently asked questions

What is the cheapest compounded tirzepatide online right now?

The lowest publicly verified starting price is Embody at $129/month (personalized blends; the source flags extra scrutiny on ingredient transparency). Verified July 2026 via the RangeYourself index. Compounded tirzepatide is not FDA-approved.

How current are these tirzepatide prices?

They are entry-tier and rise with dose toward 15 mg. Confirm the price at your target dose at checkout.

Why isn't NexLife in the RangeYourself table?

The RangeYourself index audits 14 specific providers and does not include NexLife. We cite NexLife's flat tirzepatide pricing from its own published rates and show it alongside - not inside - the third-party table, clearly marked.

How does compounded tirzepatide compare to LillyDirect?

Lilly's LillyDirect self-pay Zepbound vials run $299-449/month - the FDA-approved brand product, usually more than the cheapest compounded programs but a middle path worth pricing. Compounded tirzepatide is not FDA-approved.

Methodology & attribution

Tirzepatide starting prices are read from each provider's published tirzepatide rate. Machine-readable copy: /data/verified-price-index.json . NexLife pricing is from the provider's published rates and reflects our editorial assessment. Prices are entry-tier and change; verify with each provider. Compounded tirzepatide is not FDA-approved.

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 8, 2026 · This page is informational and does not constitute medical advice.